Bionano Genomics, Inc. (BNGO)

Bionano Genomics Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	27.43	30.78	36.12	27.8	17.98	8.5
Revenue	27.43	30.78	36.12	27.8	17.98	8.5
Revenue Growth (YoY)	-25.02%	-14.79%	29.90%	54.62%	111.47%	-16.06%
Cost of Revenue	26.04	30.4	26.55	21.86	14.11	5.73
Gross Profit	1.39	0.38	9.57	5.95	3.87	2.77
Selling, General & Admin	38.59	51.86	94.22	86.48	56.92	29.57
Research & Development	13.49	24.8	54.03	49.05	22.49	10.26
Operating Expenses	52.08	76.66	148.25	135.53	79.41	39.82
Operating Income	-50.7	-76.28	-138.69	-129.58	-75.54	-37.05
Interest Expense	-0.56	-2.04	-5.12	-0.3	-0.93	-2.52
Interest & Investment Income	1.17	2.1	3.31	1.51	0.24	-
Other Non Operating Income (Expenses)	4.55	-4.69	-15.38	-0.12	-0.06	-0.01
EBT Excluding Unusual Items	-45.54	-80.9	-155.87	-128.5	-76.29	-39.58
Merger & Restructuring Charges	-2.18	-8.02	-0.74	-1.8	-1.5	-1.5
Impairment of Goodwill	-	-	-77.28	-	-	-
Gain (Loss) on Sale of Investments	-	-	-	-0.1	-	-
Asset Writedown	-19.24	-19.68	-	-	-	-
Other Unusual Items	-7.34	-3.38	1.46	-0.32	-0.37	-
Pretax Income	-74.29	-111.98	-232.43	-130.71	-78.15	-41.08
Income Tax Expense	0.04	0.03	0.06	1.88	-5.72	0.03
Net Income	-74.33	-112.02	-232.49	-132.6	-72.44	-41.11
Net Income to Common	-74.33	-112.02	-232.49	-132.6	-72.44	-41.11
Shares Outstanding (Basic)	2	1	1	0	0	0
Shares Outstanding (Diluted)	2	1	1	0	0	0
Shares Change (YoY)	183.33%	123.37%	18.05%	4.49%	165.50%	596.04%
EPS (Basic)	-32.25	-88.13	-408.60	-275.09	-157.02	-236.58
EPS (Diluted)	-32.25	-88.13	-408.60	-275.09	-157.02	-236.58
Free Cash Flow	-26.06	-69.03	-126.87	-128.02	-73.39	-38.31
Free Cash Flow Per Share	-11.31	-54.31	-222.97	-265.58	-159.09	-220.51
Gross Margin	5.06%	1.23%	26.49%	21.38%	21.55%	32.61%
Operating Margin	-184.85%	-247.85%	-384.00%	-466.09%	-420.08%	-435.74%
Profit Margin	-271.02%	-363.97%	-643.74%	-476.93%	-402.84%	-483.43%
Free Cash Flow Margin	-95.03%	-224.28%	-351.29%	-460.46%	-408.14%	-450.59%
EBITDA	-37.86	-62.26	-124.98	-119.96	-72.18	-35.57
EBITDA Margin	-138.03%	-202.29%	-	-	-	-
D&A For EBITDA	12.84	14.02	13.71	9.62	3.35	1.48
EBIT	-50.7	-76.28	-138.69	-129.58	-75.54	-37.05
EBIT Margin	-184.85%	-247.85%	-	-	-	-
Revenue as Reported	27.43	30.78	36.12	27.8	17.98	8.5

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q